Product Details
BUY ZEPBOUND INJECTION UK
BUY ZEPBOUND INJECTION UK
Zepbound (tirzepatide) is a once-weekly, injectable prescription medication approved for chronic weight management in adults with obesity or overweight (with at least one weight-related condition). It acts as a dual GIP and GLP-1 receptor agonist, reducing appetite and improving fullness to aid weight loss in conjunction with diet and exercise.
Key Aspects of Zepbound
- Effectiveness: In clinical trials (SURMOUNT-5), patients taking Zepbound experienced significant weight loss, with some studies showing a ~20% reduction in body weight over 72 weeks.
- Administration: It is a weekly injection administered under the skin (subcutaneously) in the stomach, thigh, or upper arm.
- Dosage: Treatment typically starts at 2.5 mg for 4 weeks, with increases in 2.5 mg increments to maintenance doses of 5 mg, 10 mg, or 15 mg, based on tolerance and effectiveness.
-
- Side Effects: Common side effects are primarily gastrointestinal, including nausea, diarrhea, vomiting, constipation, and stomach pain.
- Other Uses: It is also approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity.
- Limitations: It should not be used with other GLP-1 receptor agonists or tirzepatide products (e.g., Mounjaro).
Zepbound +5
BUY ZEPBOUND INJECTION UK
Who Can Use Zepbound?
It is intended for individuals with a body mass index (BMI) of:- 30 kg/m² or greater (obesity).
- 27 kg/m² or greater (overweight) with at least one weight-related condition (e.g., hypertension, type 2 diabetes, dyslipidemia).
Additional information
| Dosage | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg |
|---|





